Related Experiment Video
Updated: Apr 4, 2026

Pluripotent Stem Cell Derived Cardiac Cells for Myocardial Repair
Published on: February 3, 2017
Concise Review: Pluripotent Stem Cell-Derived Cardiac Cells, A Promising Cell Source for Therapy of Heart Failure:
Elodie Gouadon1, Thomas Moore-Morris2, Nicoline W Smit3
1INSERM UMR-S999, LabEx LERMIT, IPSIT Centre Chirurgical Marie Lanelongue, Le Plessis Robinson, Paris, France.
Insights
Pluripotent stem cells offer potential for cardiac regeneration, but current therapies face challenges. This review addresses challenges and proposes guidelines for safe and effective clinical translation of stem cell therapies for heart failure.
Area of Science:
- Regenerative Medicine
- Cardiology
- Stem Cell Biology
Background:
- Heart failure remains a leading cause of hospitalization and mortality globally.
- Multipotent stem cell therapies have shown limited patient benefit in cardiac regenerative medicine.
- Pluripotent stem cells are being investigated as an alternative cell source for cardiac repair.
Purpose of the Study:
- To review pluripotent stem cells as a source for cardiac regeneration.
- To identify and discuss challenges associated with pluripotent stem cell therapy for heart conditions.
- To propose guidelines for translating these therapies into safe and effective clinical trials.
Main Methods:
- Comprehensive review of existing literature on pluripotent stem cells in cardiac regeneration.
- Analysis of challenges including cell delivery, immune tolerance, and proarrhythmic effects.
- Discussion of drug-mediated interventions and suitable pathological conditions.
Main Results:
- Current stem cell therapies for heart failure have demonstrated limited clinical efficacy.
- Significant challenges exist in optimizing cell delivery, ensuring immune tolerance of allogeneic cells, and mitigating proarrhythmic risks.
- Drug-mediated interventions may enhance cell grafting, and specific pathological conditions could benefit from this approach.
Conclusions:
- Pluripotent stem cells present a promising avenue for cardiac regeneration, but clinical translation requires overcoming substantial hurdles.
- Addressing cell delivery systems, immune responses, and safety concerns is crucial for therapeutic success.
- Established guidelines for cell types and delivery methods are essential for advancing pluripotent stem cell-based cardiac therapies into clinical practice.
Abstract:
Heart failure is still a major cause of hospitalization and mortality in developed countries. Many clinical trials have tested the use of multipotent stem cells as a cardiac regenerative medicine. The benefit for the patients of this therapeutic intervention has remained limited. Herein, we review the pluripotent stem cells as a cell source for cardiac regeneration. We more specifically address the various challenges of this cell therapy approach. We question the cell delivery systems, the immune tolerance of allogenic cells, the potential proarrhythmic effects, various drug mediated interventions to facilitate cell grafting and, finally, we describe the pathological conditions that may benefit from such an innovative approach. As members of a transatlantic consortium of excellence of basic science researchers and clinicians, we propose some guidelines to be applied to cell types and modes of delivery in order to translate pluripotent stem cell cardiac derivatives into safe and effective clinical trials.
Related Concept Videos
iPS Cell Differentiation
Stem Cell Culture
Induced Pluripotent Stem Cells
Induced Pluripotent Stem Cells
Somatic...
Stem Cell Therapy for Tissue Regeneration
Types of Stem Cells used in Stem Cell Therapy
The two main cell...
EPS and iPS Cells in Disease Research

